Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients

Fig. 5

Patient Global Impression of Improvement (PGI-I) and Clinical Global Impressions–Global Improvement (CGI-I) ratings at the end of treatment. PGI-I and CGI-I scores were recorded on a 7-point scale where 1 = very much better/improved, 2 = much better/improved, 3 = a little better/improved, 4 = no change, 5 = a little worse, 6 = much worse, and 7 = very much worse. *p < 0.05 vs. placebo

Back to article page